HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Lymphoma Research

Lymphoma Research

Lymphoma research stands at the forefront of cancer investigation, delving deep into understanding the complexities of this heterogeneous disease. Scientists explore various facets, from elucidating the genetic underpinnings to deciphering the immune responses involved. Novel therapies such as immunotherapy and targeted treatments emerge from this research, offering hope to patients with lymphomas resistant to conventional approaches. Clinical trials, a cornerstone of lymphoma research, pave the way for breakthroughs, evaluating new drugs and treatment combinations. Furthermore, researchers delve into personalized medicine, tailoring treatments based on individual genetic profiles to enhance efficacy and minimize side effects. Collaborative efforts across disciplines drive progress, with the ultimate goal of improving outcomes and quality of life for those affected by lymphoma.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp